These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response? Kong WT; Zhang WW; Guo HQ; Qiu JL; Tang M; Jiang ZM; Shen Y; Li XG; Zhang SW Abdom Imaging; 2011 Jun; 36(3):342-7. PubMed ID: 21107560 [TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experience. Yamakado K; Nakatsuka A; Kobayashi S; Akeboshi M; Takaki H; Kariya Z; Kinbara H; Arima K; Yanagawa M; Hori Y; Kato H; Sugimura Y; Takeda K Cardiovasc Intervent Radiol; 2006; 29(3):389-94. PubMed ID: 16502180 [TBL] [Abstract][Full Text] [Related]
11. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center. Zhou W; Uppot RN; Feldman AS; Arellano RS AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572 [TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. Gervais DA; McGovern FJ; Arellano RS; McDougal WS; Mueller PR AJR Am J Roentgenol; 2005 Jul; 185(1):64-71. PubMed ID: 15972400 [TBL] [Abstract][Full Text] [Related]
13. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients. Memarsadeghi M; Schmook T; Remzi M; Weber M; Pötscher G; Lammer J; Kettenbach J Eur J Radiol; 2006 Aug; 59(2):183-9. PubMed ID: 16725292 [TBL] [Abstract][Full Text] [Related]
14. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease. Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786 [TBL] [Abstract][Full Text] [Related]
15. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment? Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792 [TBL] [Abstract][Full Text] [Related]
16. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment. Wells SA; Wheeler KM; Mithqal A; Patel MS; Brace CL; Schenkman NS Abdom Radiol (NY); 2016 Jun; 41(6):1203-11. PubMed ID: 27167230 [TBL] [Abstract][Full Text] [Related]
17. Experiences in US-guided percutaneous radiofrequency ablation of 44 renal tumors in 31 patients: analysis of predictors for complications and technical success. Veltri A; Calvo A; Tosetti I; Pagano E; Genovesio A; Virzì V; Ferrando U; Fontana D; Gandini G Cardiovasc Intervent Radiol; 2006; 29(5):811-8. PubMed ID: 16832595 [TBL] [Abstract][Full Text] [Related]
18. Percutaneous radio frequency ablation of renal tumors in patients with von Hippel-Lindau disease: preliminary results. Park BK; Kim CK J Urol; 2010 May; 183(5):1703-7. PubMed ID: 20299060 [TBL] [Abstract][Full Text] [Related]
19. Chyluria after radiofrequency ablation of renal tumors. Kaur H; Matin SF; Javadi S; Johnson VE; Choi H; Sandler C; Ahrar K J Vasc Interv Radiol; 2011 Jul; 22(7):924-7. PubMed ID: 21507680 [TBL] [Abstract][Full Text] [Related]
20. US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results. Yu J; Liang P; Yu XL; Cheng ZG; Han ZY; Mu MJ; Wang XH Radiology; 2012 Jun; 263(3):900-8. PubMed ID: 22495684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]